HALIFAX, April 15 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,
NASDAQ: MMIRF), a global market leader in premium rapid diagnostic solutions,
announced today that it is gaining healthy market traction and realizing
steady sales of the company's rapid HIV tests in Eastern Europe and Colombia.
To date two orders have been shipped to Romania and four orders to Colombia.
MedMira's rapid HIV tests have received a very favourable response from the
company's distributors and their customers in these markets.
